Incyte
INCY
#1201
Rank
โ‚น1.883 T
Marketcap
โ‚น9,428
Share price
-2.19%
Change (1 day)
53.28%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): โ‚น650.47

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น689.96. In 2025 the company made an earnings per share (EPS) of โ‚น623.80 an increase over its 2024 EPS that were of โ‚น29.30.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น650.474.28%
2025โ‚น623.802029.03%
2024โ‚น29.30-88.39%
2023โ‚น252.3673.38%
2022โ‚น145.55-64.1%
2021โ‚น405.47-408.63%
2020-โ‚น131.38-166.83%
2019โ‚น196.59300%
2018โ‚น49.15-133.33%
2017-โ‚น147.44-378.57%
2016โ‚น52.932700%
2015โ‚น1.89-106.67%
2014-โ‚น28.35-44.44%
2013-โ‚น51.0450%
2012-โ‚น34.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น663.50-3.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น123.81-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,668 286.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,369 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น595.44-13.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.29-101.78%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น54.82-107.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น79.39-111.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น21.74-103.15%๐Ÿ‡บ๐Ÿ‡ธ USA